Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Rigel: Q3 Earnings Snapshot AP - Thu Nov 7, 3:09PM CST

Rigel: Q3 Earnings Snapshot

RIGL : 22.74 (-5.64%)
Rigel: Q2 Earnings Snapshot AP - Tue Aug 6, 3:25PM CDT

Rigel: Q2 Earnings Snapshot

RIGL : 22.74 (-5.64%)
Rigel: Q1 Earnings Snapshot AP - Tue May 7, 3:47PM CDT

Rigel: Q1 Earnings Snapshot

RIGL : 22.74 (-5.64%)
Rigel: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Rigel: Q3 Earnings Snapshot

RIGL : 22.74 (-5.64%)
Rigel Announces Presentation at the Upcoming IDWeek 2023 PR Newswire - Wed Oct 11, 2023

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced an upcoming oral presentation highlighting data from the FOCUS Phase 3 clinical...

RIGL : 22.74 (-5.64%)
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Fri Oct 6, 2023

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel's Inducement Plan, approved...

RIGL : 22.74 (-5.64%)
Rigel to Present at the 2023 Cantor Global Healthcare Conference PR Newswire - Wed Sep 20, 2023

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company...

RIGL : 22.74 (-5.64%)
Rigel to Participate in Upcoming September Investor Conferences PR Newswire - Wed Aug 30, 2023

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, and Dean...

RIGL : 22.74 (-5.64%)
Rigel: Q2 Earnings Snapshot AP - Tue Aug 1, 2023

Rigel: Q2 Earnings Snapshot

RIGL : 22.74 (-5.64%)
Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update PR Newswire - Tue Aug 1, 2023

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the second quarter ended June 30, 2023, including sales of...

RIGL : 22.74 (-5.64%)

Barchart Exclusives

Can Nvidia Stock Rally After Q3 Earnings This Week? Barchart - 1 hour ago
Valued at a market cap of $3.5 trillion, Nvidia is a big tech giant that continues to grow at an enviable pace, even as major earnings beats have become routine. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot